Data from Braking Bad: Blockade of Inhibitory Pathways Improves Interleukin-15 Therapy
Year: 2023
Type: other
Abstract: Blockade of the CTLA-4 and PD-1 inhibitory pathways in T cells via the administration of neutralizing antibodies at the time of interleukin (IL)-15 therapy markedly enhanced the survival of tumor-bearing mice as compared with those receiving IL-15 alone or IL-15 in combination with just one of the antibodies. Clin Cancer Res; 16(24); 5917–9. ©2010 AACR.
Author: William E. Carson
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4361943798